drugset
Drugs / Measles-Rubella (MR) Vaccine
last change Aug 2018 re-read 3 minutes ago

Measles-Rubella (MR) Vaccine

Vaccine

Developed for
measles · rubella
Investigated by
Centers for Disease Control and Prevention · International Centre for Diarrhoeal Disease Research, Bangladesh · Ministry of Health and Family Welfare, Bangladesh

Trials 1

today NCT03071575 · Ph 4
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT03071575 Mar 2017 → Mar 2018 congenital rubella syndrome, measles Centers for Disease Control and Prevention Completed No outcome recorded
Comparator or background therapy1 trial
Phase 4 NCT03680417 Comparator Nov 2017 → Feb 2018 — PT Bio Farma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Measles-rubella (MR) vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03071575 ↗
1

NCT03680417 ↗
Modality Vaccine “measles-rubella (MR) vaccine” NCT03071575 ↗